BAVA:CPH
巴伐利亞北歐
DKK 236.80
arrow_upward
+0.68%(+1.60) 1 天
10月15日, GMT+2 15:25:32 · DKK
search
所有股票代码
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 BAVA 生成关键数据洞见…
开盘价
DKK 236.00
最高价
DKK 238.40
最低价
DKK 234.20
市值
187.70亿
平均成交量
17.92万
成交量
8.84万
52 周最高价
DKK 243.70
52 周最低价
DKK 171.30
流通股数
7926.53万
员工人数
1906
开盘价
DKK 236.00
最高价
DKK 238.40
最低价
DKK 234.20
市值
187.70亿
平均成交量
17.92万
成交量
8.84万
52 周最高价
DKK 243.70
52 周最低价
DKK 171.30
流通股数
7926.53万
员工人数
1906
新闻报道
来自网络来源和新闻合作伙伴
资料
Bavarian Nordic A/S is a Danish biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany, as well as offices in USA, Canada, and France. The company uses viral vectors and virus-like particles in its research and development.
In July 2025, the company agreed to be acquired by private equity firms Permira and Nordic Capital for 19 billion kr. However, in November, the acquisition failed to gain sufficient support from Bavarian Nordic's shareholders, leading to its termination.
In 2026, Bavarian Nordic was ranked second in Time Magazine's World Most Impactful Companies. Wikipedia
巴伐利亞北歐简介